VEGFA and colorectal cancer: The possible link between LDH levels and tumor angiogenesis has been indicated in 2 different clinical trials (the CONFIRM 1 & 2 trials) investigating PTK/ZK (vatalanib), an oral inhibitor of VEGF (vascular endothelial growth factor) receptors, in first and second-line therapy of advanced colorectal cancer.